Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about TASE:KDST

Recent news which mentions TASE:KDST

The World Prestigious Diabetes Research Institute, University of Miami, Announces Kadimastem's Joint Project as Breakthrough Transplantation Approach for the Treatment of Type 1 Diabetes
Tags TASE:KDST
From News Direct
Kadimastem Takes Another Step Towards Signing the Merger Agreement with Nasdaq Listed IMCC
Tags TASE:KDST
From News Direct
Kadimastem advances towards Nasdaq: Company Signs a Memorandum of Understanding to Merge with a Company traded on the Nasdaq
Tags TASE:KDST
From News Direct
Kadimastem Receives Patent for Its Cell Selection and Enrichment Technology Used to Develop Its IsletRx Treatment for Diabetes in India
Tags TASE:KDST
From News Direct
A peer reviewed article on Kadimastem's AstroRx® Cryopreserved off the Shelf Cell Product for the Treatment of ALS was Published in the Journal of Clinical Toxicology
Tags TASE:KDST
From News Direct
Kadimastem and iTolerance Complete Initial Targeted Engagement for Regulatory Advice on CBER Products (INTERACT) Meeting with the U.S. FDA
Tags TASE:KDST
From News Direct
Kadimastem and iTolerance Submit Initial Targeted Engagement for Regulatory Advice on CBER Products (INTERACT) Meeting Request with FDA for Potential Cure for Type 1 Diabetes
Tags TASE:KDST
From News Direct
Kadimastem Receives US Patent for Its Cell Selection and Enrichment Technology Used to Develop Its IsletRx Treatment for Diabetes
Tags TASE:KDST
From News Direct
Kadimastem Granted European Patent for Its Cell Selection and Enrichment Technology Used to Develop Its IsletRx Treatment for Diabetes
Tags TASE:KDST
From News Direct
Kadimastem and iTolerance Sign Agreement and Receive US$1 Million from BIRD Foundation
Tags TASE:KDST
From News Direct
Kadimastem Earns FDA Approval of its IND Application For its US Multi-Site Phase IIa Clinical Trial of AstroRx® to Treat ALS
Tags TASE:KDST
From News Direct
Kadimastem Submits IND Application to the FDA for its Phase IIa Clinical Trial with AstroRx® for the Treatment of ALS
Tags TASE:KDST
From News Direct
Kadimastem's Clinical Trial in ALS Patients was Publicized in the Journal of Translational Medicine
Tags TASE:KDST
From News Direct
Kadimastem Awarded Patent in Australia for its AstroRx® Technology for the Treatment of ALS and Drug Screening
Tags TASE:KDST
From News Direct
Kadimastem Receives US Patent For Amyotrophic Lateral Sclerosis (ALS) Treatment
Tickers ALS
Tags TASE:KDST
From News Direct
Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards the Potential Licensing of “Immune Evasive” Cells
Tags TASE:KDST
From News Direct
Kadimastem Awarded Patent in Japan for AstroRx® For ALS and Drug Screening
Tags TASE:KDST
From News Direct
Kadimastem Expands R&D Program to Include Multiple Sclerosis
Tags TASE:KDST
From News Direct
Kadimastem Receives Grant for a Total Budget of NIS 10 Million ($3.1 million) from the Israeli Innovation Authority
Tags TASE:KDST
From News Direct
Kadimastem Announces the Approval of a 4M NIS ($1.29M) Budget from the Israel Innovation Authority
Tags TASE:KDST
From News Direct
Kadimastem Raises $5 million In Private Placement
Tags TASE:KDST
From News Direct
Kadimastem Raises NIS 16.1 million ($5 million) In Private Placement
Tags TASE:KDST
From News Direct
Kadimastem Holds Successful Preliminary Meeting with the FDA (INTERACT) Regarding IsletRx for the Treatment of Diabetes
Tags TASE:KDST
From News Direct
Kadimastem Patent for cell selection of beta cells to Treat and Potentially Cure Diabetes was Granted in Japan
Tags TASE:KDST
From News Direct
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.